AC Immune SA
ACIU
$1.68
$0.021.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.99% | 4.87% | 39.96% | 4.24% | 15.27% |
| Total Depreciation and Amortization | 0.59% | -0.42% | 0.50% | 1.82% | 1.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.74% | 2.68% | 109.05% | 162.32% | 48.54% |
| Change in Net Operating Assets | 1,731.75% | 799.81% | 8,291.51% | 3,753.75% | 224.71% |
| Cash from Operations | 204.92% | 207.63% | 170.58% | 173.66% | 32.05% |
| Capital Expenditure | 19.33% | 26.33% | 0.70% | -55.40% | -2.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -101,505.99% | -260.04% | -266.47% | -291.29% | -100.12% |
| Cash from Investing | -8,234.19% | -262.93% | -270.36% | -296.07% | -101.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -32.59% | -24.64% | -17.93% | -11.15% | -3.02% |
| Issuance of Common Stock | -99.69% | -99.69% | 1,469.90% | 1,934.89% | 729,900.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 94.20% | -- | -6,737.50% | -2,442.86% | -3,592.86% |
| Cash from Financing | -101.62% | -102.62% | 1,844.74% | 2,646.94% | 8,152.41% |
| Foreign Exchange rate Adjustments | -1,978.45% | -2.95% | -1,505.73% | -893.47% | -27.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7,989.77% | -192.98% | 99.00% | 153.16% | -171.25% |